Results 281 to 290 of about 14,877 (300)

Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction

Journal of the American College of Cardiology, 2013
Ingo Eitel, Matthias Gutberlet, Holger Thiele   +2 more
exaly  

One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.

EuroIntervention, 2013
S. Schulz, A. Kastrati, Miroslaw Ferenc, S. Massberg, K. A. Birkmeier, K. Laugwitz, S. Kufner, M. Gick, M. Dommasch, H. Schühlen, A. Schömig, P. Berger, J. Mehilli, F. Neumann   +13 more
semanticscholar   +1 more source

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up

European Heart Journal, 2007
David Antoniucci, Adnan Kastrati, Eric Vicaut   +2 more
exaly  

Randomized trial of standard versus ClearWay-infused abciximab and thrombectomy in myocardial infarction: rationale and design of the COCTAIL II study

Journal of Cardiovascular Medicine, 2013
F. Prati, L. Di Vito, V. Ramazzotti, F. Imola, T. Pawlowski, Laura Materia, L. Tavazzi, G. Biondi‐Zoccai, M. Albertucci   +8 more
semanticscholar   +1 more source

Abciximab

Reactions Weekly, 1998
openaire   +1 more source

Abciximab

Reactions Weekly, 1999
openaire   +3 more sources

Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention

Catheterization and cardiovascular interventions, 2013
S. Pyxaras, F. Mangiacapra, K. Verhamme, L. Di Serafino, F. De Vroey, G. Toth, A. Perkan, A. Salvi, J. Bartunek, B. de Bruyne, W. Wijns, G. Sinagra, E. Barbato   +12 more
semanticscholar   +1 more source

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction

Journal of the American College of Cardiology, 2003
David Antoniucci, Guido Parodi, Leonardo Bolognese   +2 more
exaly  

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

The Lancet, 2001
M. Simoons
semanticscholar   +1 more source

Molecular Imaging of Human Thrombus With Novel Abciximab Immunobubbles and Ultrasound

Stroke, 2007
Angelika Alonso, Martin Griebe
exaly